Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mathematical models and individualized outcome estimates in multiple sclerosis.

C Confavreux1, C Wolfson

  • 1Clinique de Neurologie, Hôpital Neurologique, Lyon, France.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1989
PubMed
Summary

Developing personalized prognosis for multiple sclerosis (MS) is crucial for effective treatment. New mathematical models offer individualized outcome estimates, improving patient care for this variable disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations.

Journal of bone oncology·2021
Same author

Variabilities in µQCT-based FEA of a tumoral bone mice model.

Journal of biomechanics·2021
Same author

[Pharmaceutical interviews for rheumatoid arthritis patients: Perceptions and expectations of community pharmacists].

Annales pharmaceutiques francaises·2018
Same author

High burden of neurological disease in the older general population: results from the Canadian Longitudinal Study on Aging.

European journal of neurology·2018
Same author

Effect of intra-tibial injection on mechanical properties of mouse bone.

Computer methods in biomechanics and biomedical engineering·2017

Area of Science:

  • Neurology
  • Biostatistics
  • Mathematical Modeling

Background:

  • Multiple sclerosis (MS) presents a wide spectrum of disease severity, necessitating individualized outcome predictions for optimal therapeutic selection.
  • Current prognostic methods are often insufficient for tailoring treatments to individual patients with MS.
  • Accurate prognosis is essential for managing the variable clinical courses of MS, ranging from benign to malignant forms.

Purpose of the Study:

  • To develop and evaluate probabilistic mathematical models for generating individualized outcome estimates in multiple sclerosis.
  • To provide a framework for personalized prognosis by integrating multiple prognostic variables.
  • To enhance the ability to predict disease course likelihood and prognosis for individual MS patients.

Main Methods:

Related Experiment Videos

  • Utilized probabilistic mathematical models, including an initial Markov model and a subsequently developed stochastic survival model.
  • Analyzed data from 278 definite and probable MS cases collected over a 20-year period (1957-1976).
  • The stochastic survival model allows for the incorporation of actual values of quantitative prognostic variables for personalized predictions.

Main Results:

  • The initial Markov model provided a general overview but lacked individual patient relevance and limited prognostic variable analysis.
  • The elaborated stochastic survival model, though complex theoretically, proved practical for generating personalized prognoses.
  • This model enables the combination of multiple prognostic variables, including quantitative ones, for tailored outcome estimation.

Conclusions:

  • Probabilistic mathematical models, particularly the stochastic survival model, offer a novel approach to individualized outcome estimation in multiple sclerosis.
  • These models provide a global description of disease course likelihood and prognosis, adaptable to individual patients.
  • Further refinement and validation are necessary, but these models represent a significant advancement in personalized MS prognosis.